Literature DB >> 25820528

Animal and cellular models of hepatocellular carcinoma bone metastasis: establishment and characterisation.

Rui Hou1, Yu-Wei Wang2, Hui-Fang Liang2, Zhan-Guo Zhang2, Zhi-Min Liu3, Bin-Hao Zhang2, Bi-Xiang Zhang4, Xiao-Ping Chen5.   

Abstract

BACKGROUND: An increasingly high occurrence of bone metastases in hepatocellular carcinoma (HCC) patients highlights the importance of fundamental research on HCC bone metastasis, which has been limited in its success due to the lack of a model system.
PURPOSE: Establishment of animal and cellular models of HCC bone metastasis and discovery of HCC bone metastasis-related genes.
METHODS: Luciferase-transfected HCC cell lines HCCLM3, MHCC97H, and SMMC-7721 were used to inoculate nude mice intracardially. Formation of bone metastases was examined by bioluminescence imaging, SPECT, and pathology study. Metastatic cells in bone were isolated and subcultured. Differences between bone metastatic cells and their parental cells were studied by in vitro/in vivo assays.
RESULTS: Mouse model of HCC bone metastasis was successfully established. Injected tumour cells formed metastases in the skull, the spine, the hind limbs, and the sternum, causing osteolytic lesions via act of MMP-1 and recruitment of osteoclasts. Four bone metastatic cell lines were extracted from HCCLM3-inoculated mice and were demonstrated to exhibit a much stronger ability to form bone metastases as well as other phenotypes, including enhanced in vitro migration/invasion and colony formation. Moreover, the expression of PTHrP, MMP-1, and CTGF was significantly elevated in bone metastatic cells compared to parental HCC cells.
CONCLUSION: The nude mouse model and bone metastatic cell lines together provide an effective simulation of HCC bone metastasis. This model system will become powerful tool with which to explore the mechanisms and therapies of HCC bone metastasis. Additionally, PTHrP, MMP-1, and CTGF are candidate genes related to HCC bone metastasis.

Entities:  

Keywords:  Animal model; Bone metastasis; CTGF; Cell line; Hepatocellular carcinoma; MMP-1; Osteoclasts; PTHrP

Mesh:

Substances:

Year:  2015        PMID: 25820528     DOI: 10.1007/s00432-015-1958-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  32 in total

1.  Characterization of a new renal cell carcinoma bone metastasis mouse model.

Authors:  Anne Strube; Elizaveta Stepina; Dominik Mumberg; Arne Scholz; Peter Hauff; Sanna-Maria Käkönen
Journal:  Clin Exp Metastasis       Date:  2010-05-05       Impact factor: 5.150

Review 2.  Jekyll and Hyde: the role of the microenvironment on the progression of cancer.

Authors:  Michael Allen; J Louise Jones
Journal:  J Pathol       Date:  2010-10-29       Impact factor: 7.996

3.  Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions.

Authors:  O Peyruchaud; B Winding; I Pécheur; C M Serre; P Delmas; P Clézardin
Journal:  J Bone Miner Res       Date:  2001-11       Impact factor: 6.741

4.  [Surgical treatment of liver cancer: experience of the A Coruña UHC (Spain)].

Authors:  Marlén Alvite Canosa; Salvador Pita Fernández; Julia Quintela Fandiño; Javier Aguirrezabalaga; Alejandra Otero; Francisco Suárez; Gerardo Corbal; Carlos Fernández; Manuel Gómez Gutiérrez
Journal:  Cir Esp       Date:  2011-02-26       Impact factor: 1.653

5.  Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2.

Authors:  E I Deryugina; G X Luo; R A Reisfeld; M A Bourdon; A Strongin
Journal:  Anticancer Res       Date:  1997 Sep-Oct       Impact factor: 2.480

6.  Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging.

Authors:  Justin M Drake; Curtis L Gabriel; Michael D Henry
Journal:  Clin Exp Metastasis       Date:  2006-05-16       Impact factor: 5.150

7.  PET/CT characteristics of isolated bone metastases in hepatocellular carcinoma.

Authors:  Chi-Lai Ho; Sirong Chen; Thomas Kam Chau Cheng; Yim Lung Leung
Journal:  Radiology       Date:  2010-11-09       Impact factor: 11.105

8.  A multigenic program mediating breast cancer metastasis to bone.

Authors:  Yibin Kang; Peter M Siegel; Weiping Shu; Maria Drobnjak; Sanna M Kakonen; Carlos Cordón-Cardo; Theresa A Guise; Joan Massagué
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

Review 9.  Modeling metastasis in vivo.

Authors:  Chand Khanna; Kent Hunter
Journal:  Carcinogenesis       Date:  2004-09-09       Impact factor: 4.944

Review 10.  [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].

Authors:  H Neeff; F Makowiec; J Harder; V Gumpp; A Klock; R Thimme; O Drognitz; U T Hopt
Journal:  Zentralbl Chir       Date:  2009-04-20       Impact factor: 0.942

View more
  8 in total

Review 1.  Bone metastasis of hepatocellular carcinoma: facts and hopes from clinical and translational perspectives.

Authors:  Zhao Huang; Jingyuan Wen; Yufei Wang; Shenqi Han; Zhen Li; Xuemei Hu; Dongling Zhu; Zhenxiong Wang; Junnan Liang; Huifang Liang; Xiao-Ping Chen; Bixiang Zhang
Journal:  Front Med       Date:  2022-07-19       Impact factor: 9.927

2.  Response of Scalp and Skull Metastasis to Anti-PD-1 Antibody Combined with Regorafenib Treatment in a Sorafenib-Resistant Hepatocellular Carcinoma Patient and a Literature Review.

Authors:  Xin Long; Lei Zhang; Wen-Qiang Wang; Er-Lei Zhang; Xing Lv; Zhi-Yong Huang
Journal:  Onco Targets Ther       Date:  2022-06-29       Impact factor: 4.345

3.  The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma.

Authors:  Li Zhang; Hao Niu; Jie Ma; Bao-Ying Yuan; Yu-Han Chen; Yuan Zhuang; Gen-Wen Chen; Zhao-Chong Zeng; Zuo-Lin Xiang
Journal:  Mol Cancer       Date:  2019-07-26       Impact factor: 27.401

4.  RNF219/α-Catenin/LGALS3 Axis Promotes Hepatocellular Carcinoma Bone Metastasis and Associated Skeletal Complications.

Authors:  Shuxia Zhang; Yingru Xu; Chan Xie; Liangliang Ren; Geyan Wu; Meisongzhu Yang; Xingui Wu; Miaoling Tang; Yameng Hu; Ziwen Li; Ruyuan Yu; Xinyi Liao; Shuang Mo; Jueheng Wu; Mengfeng Li; Erwei Song; Yanfei Qi; Libing Song; Jun Li
Journal:  Adv Sci (Weinh)       Date:  2020-12-31       Impact factor: 16.806

Review 5.  Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application.

Authors:  Sha Liu; Fang Huang; Guoqing Ru; Yigang Wang; Bixiang Zhang; Xiaoping Chen; Liang Chu
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

Review 6.  CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?

Authors:  Qingan Jia; Qiongzhu Dong; Lunxiu Qin
Journal:  Oncotarget       Date:  2016-01-12

7.  Effects of connective tissue growth factor on prostate cancer bone metastasis and osteoblast differentiation.

Authors:  Shuangli Zhang; Baolin Li; Wei Tang; Linying Ni; Huili Ma; Ming Lu; Qinggang Meng
Journal:  Oncol Lett       Date:  2018-06-13       Impact factor: 2.967

Review 8.  CCN proteins in the musculoskeletal system: current understanding and challenges in physiology and pathology.

Authors:  Veronica Giusti; Katia Scotlandi
Journal:  J Cell Commun Signal       Date:  2021-07-06       Impact factor: 5.782

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.